background: omega-3 fatty acids have established beneficial effects for cardiovascular disease. the use of omega-3 supplements for patients with non-alcoholic fatty liver disease (nafld) was proposed. the purpose of this study was to review the relationship between omega-3 fatty acids intake and nafld. methods: in this study, the terms such as nafld, omega-3 fatty acids, docosahexanoic acid, an...

Fatty liver or hepatic steatosis is a common and often occasional finding for the general practitioner. 1 After exclusion of less common causes of fatty liver such as Hepatitis B or C infection, drugs and autoimmune disorders, fatty liver is classified as non-alcoholic (NAFLD) or alcoholic fatty liver disease (AFLD) on the basis of daily eth-anol intake. The agreed threshold of ethanol intake u...

Background: Metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD) is a common public health problem. Visfatin is secreted by visceral adipose tissue and is an adipocytokine. It could be a pro-inflammatory adipocytokine and is related to the metabolic syndrome and non-alcoholic fatty liver disease. This study evaluated the association between visfatin levels in patients with the ...

Abstract Background and Aims Non-alcoholic fatty liver disease (NAFLD) is associated with endothelial dysfunction which a common problem in hemodialysis patients risk for high cardiovascular mortality hemodialysis. Thrombomodulin promising marker of cell injury different pathological conditions. This study evaluates the additive effect non-alcoholic prevalent HD on dysfunction. Methods A case-c...

Non-alcoholic fatty liver disease (NAFLD) represents a spectrum of conditions characterized by macrovesicular hepatic steatosis in the absence of significant alcohol intake (less than 20 gm/day for males and 10 gm/day for females). Two main histological patterns are recognized: 1. Steatosis without inflammation; and 2. steatohepatitis (NASH) with inflammation, fibrosis and cirrhosis. NAFLD is a...

non-alcoholic fatty liver disease (naflD) has emerged as a worldwide epidemic in the 21st century. the spectrum of its histopathology ranges from simple steatosis to steatohepatitis, with risk for progressive fibrosis that may lead to cirrhosis and hepatocellular carcinoma. this review is an update of the histopathology of naflD and its differential diagnosis, in particular alcoholic liver dise...

BACKGROUND Non-alcoholic fatty liver disease (NAFLD) is currently conceptualised as a clinical spectrum that results from a ‘multiple-hit’ process which begins with simple steatosis and subsequently renders the hepatocytes susceptible to a variety of insults. Ultimately, more serious liver injuries like non-alcoholic steatohepatitis (NASH) and cirrhosis may develop. Although the metabolic syndr...

Background: Fatty liver disease has been associated with increased levels of various circulating inflammatory markers. Difference in the level markers between patients AFLD and NAFLD is still unclear. Aim & Objectives: The aim present study was to compare alcoholic-fatty (AFLD) non-alcoholic fatty (NAFLD) also see if any correlation exists enzymes. Materials Methods: This conducted on 70 (3...

Non-alcoholic fatty liver disease (NAFLD) represents a clinical condition that may progress from steatosis to steatohepatitis, cirrhosis and hepatocellular carcinoma. There are not enough information about the relationship between menopause and NAFLD, and this study evaluated the relevance of this liver disease in menopausal women (MPW), and the relationship between hormone replacement therapy ...